Suchergebnisse - "Solassol, Isabelle"

PubPharm (21)

1

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Vendrell, J. | Ban, I. | Solassol, I. | +9

2

EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome

enthalten in: Translational lung cancer research | 2021

von Vendrell, J. | Quantin, X. | Aussel, A. | +3

3

FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer : Safety, Tolerability, Plasma Concentration Monitoring, and Management

enthalten in: Biomolecules | 2019

von Solassol, I. | Pinguet, F. | Quantin, X.

4

Protein interactions study through proximity-labeling

enthalten in: Expert review of proteomics | 2019

von Béganton, B. | Solassol, I. | Mangé, A. | +1

5

Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography–tandem mass spectrometry

enthalten in: Journal of pharmaceutical and biomedical analysis | 2014

von Lafaille, F. | Solassol, I. | Enjalbal, C. | +6

6

Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry

enthalten in: Journal of pharmaceutical and biomedical analysis | 2014

von Lafaille, F. | Solassol, I. | Enjalbal, C. | +6

7

Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2010

von Khier, S. | Gattacceca, F. | El Messaoudi, S. | +8

8

Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas

enthalten in: Drug metabolism and disposition | 2010

von Khier, S. | Gattacceca, F. | El Messaoudi, S. | +8

9

Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2010

von Khier, S. | Deleuze-Masquéfa, C. | Moarbess, G. | +7

10

Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma

enthalten in: European journal of pharmaceutical sciences | 2010

von Khier, S. | Deleuze-Masquéfa, C. | Moarbess, G. | +7